Literature DB >> 28112741

Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.

P D E Miller1, T I de Silva2, R Skinner3, M Gilleece4, A Peniket5, A Hamblin5, D Greenfield6, C Anthias1,7, K Peggs8, A Madrigal1, J A Snowden9,10.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28112741     DOI： 10.1038/bmt.2016.362

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes.

Authors:  A Hamblin; D M Greenfield; M Gilleece; N Salooja; M Kenyon; E Morris; N Glover; P Miller; H Braund; A Peniket; B E Shaw; J A Snowden
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

2.  Optimal approach to assessing T-cell function in haematopoietic cell transplant recipients.

Authors:  Joshua M Dorn; Roshini S Abraham; Vilmarie Rodriguez; Shakila P Khan; Heather Stefanski; Avni Joshi
Journal:  BMJ Case Rep       Date:  2018-01-23

3.  Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.

Authors:  Paul D E Miller; Alice S Forster; Thushan I de Silva; Hayley Leonard; Chloe Anthias; Michaela Mayhew; Matthias Klammer; Susan Paskar; Erin Hurst; Karl Peggs; Alejandro Madrigal; John A Snowden
Journal:  BMJ Open       Date:  2018-08-08       Impact factor: 2.692

4.  Adherence to guidelines across different specialties to prevent infections in patients undergoing immunosuppressive therapies.

Authors:  David R Chadwick; Laila Sayeed; Matthew Rose; Emily Budd; Mo Mohammed; Sarah Harrison; Jaskiran Azad; Jamie Maddox
Journal:  BMC Infect Dis       Date:  2020-05-20       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.